These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 19446499)

  • 1. Critical discussion of different dose-volume parameters for rectum and urethra in prostate brachytherapy.
    Kirisits C; Goldner G; Berger D; Georg D; Pötter R
    Brachytherapy; 2009; 8(4):353-60. PubMed ID: 19446499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate seed implantation using 3D-computer assisted intraoperative planning vs. a standard look-up nomogram: Improved target conformality with reduction in urethral and rectal wall dose.
    Raben A; Chen H; Grebler A; Geltzeiler J; Geltzeiler M; Keselman I; Litvin S; Sim S; Hanlon A; Yang J
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1631-8. PubMed ID: 15590195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deformable image registration for cervical cancer brachytherapy dose accumulation: Organ at risk dose-volume histogram parameter reproducibility and anatomic position stability.
    Flower E; Do V; Sykes J; Dempsey C; Holloway L; Summerhayes K; Thwaites DI
    Brachytherapy; 2017; 16(2):387-392. PubMed ID: 28161434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interobserver variability of 3.0-tesla and 1.5-tesla magnetic resonance imaging/computed tomography fusion image-based post-implant dosimetry of prostate brachytherapy.
    Watanabe K; Katayama N; Katsui K; Matsushita T; Takamoto A; Ihara H; Nasu Y; Takemoto M; Kuroda M; Kanazawa S
    J Radiat Res; 2019 Jul; 60(4):483-489. PubMed ID: 31083713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraoperative ultrasound-based planning can effectively replace postoperative CT-based planning for high-dose-rate brachytherapy for prostate cancer.
    Batchelar DL; Chung HT; Loblaw A; Law N; Cisecki T; Morton GC
    Brachytherapy; 2016; 15(4):399-405. PubMed ID: 27180126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interstitial rotating shield brachytherapy for prostate cancer.
    Adams QE; Xu J; Breitbach EK; Li X; Enger SA; Rockey WR; Kim Y; Wu X; Flynn RT
    Med Phys; 2014 May; 41(5):051703. PubMed ID: 24784369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of obesity on rectal dosimetry after permanent prostate brachytherapy.
    Patil N; Crook J; Saibishkumar EP; Aneja M; Borg J; Pond G; Ma C
    Brachytherapy; 2009; 8(2):218-222. PubMed ID: 19230790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of treatment planning techniques for low-dose-rate (LDR) prostate brachytherapy.
    Connolly D; Sands G; Winter H; Foley MJ; Kleefeld C
    Brachytherapy; 2021; 20(2):410-419. PubMed ID: 33234407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loose seeds vs. stranded seeds: a comparison of critical organ dosimetry and acute toxicity in (125)I permanent implant for low-risk prostate cancer.
    Saibishkumar EP; Borg J; Yeung I; Cummins-Holder C; Landon A; Crook JM
    Brachytherapy; 2008; 7(2):200-5. PubMed ID: 18362087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical organ dosimetry in permanent seed prostate brachytherapy: defining the organs at risk.
    Crook JM; Potters L; Stock RG; Zelefsky MJ
    Brachytherapy; 2005; 4(3):186-94. PubMed ID: 16182218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of various methods for rectum delineation on relative and absolute dose-volume histograms for prostate IMRT treatment planning.
    Kusumoto C; Ohira S; Miyazaki M; Ueda Y; Isono M; Teshima T
    Med Dosim; 2016; 41(2):136-41. PubMed ID: 26923466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emptying the rectum before treatment delivery limits the variations of rectal dose - volume parameters during 3DCRT of prostate cancer.
    Stasi M; Munoz F; Fiorino C; Pasquino M; Baiotto B; Marini P; Malinverni G; Valdagni R; Gabriele P
    Radiother Oncol; 2006 Sep; 80(3):363-70. PubMed ID: 16959344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dosimetric evaluation of interstitial high-dose-rate implants for localised prostate cancer].
    Fröhlich G; Agoston P; Lövey J; Somogyi A; Fodor J; Major T
    Magy Onkol; 2007; 51(1):31-8. PubMed ID: 17417673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interobserver variability in rectum contouring in high-dose-rate brachytherapy for prostate cancer: A multi-institutional prospective analysis.
    Chicas-Sett R; Celada-Alvarez F; Roldan S; Rodriguez-Villalba S; Santos-Olias M; Soler-Catalan P; Ibanez-Rosello B; Arribas L; Tormo A; Benlloch JM; Perez-Calatayud J
    Brachytherapy; 2018; 17(1):208-213. PubMed ID: 29113782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computed tomography-based high-dose-rate intracavitary brachytherapy for uterine cervical cancer: preliminary demonstration of correlation between dose-volume parameters and rectal mucosal changes observed by flexible sigmoidoscopy.
    Koom WS; Sohn DK; Kim JY; Kim JW; Shin KH; Yoon SM; Kim DY; Yoon M; Shin D; Park SY; Cho KH
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1446-54. PubMed ID: 17482766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in urethral dosimetry between CT and MR imaging in multichannel vaginal cylinder brachytherapy.
    Chen KS; Glaser SM; Kim H; Beriwal S
    Brachytherapy; 2017; 16(5):964-967. PubMed ID: 28694115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of urethral diameters for calculating the urethral dose after permanent prostate brachytherapy.
    Tanaka O; Hayashi S; Matsuo M; Nakano M; Kubota Y; Maeda S; Ohtakara K; Deguchi T; Hoshi H
    Radiat Med; 2007 Aug; 25(7):329-34. PubMed ID: 17705002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shape analysis of the prostate: establishing imaging specifications for the design of a transurethral imaging device for prostate brachytherapy guidance.
    Holmes DR; Davis BJ; Goulet CC; Wilson TM; Mynderse LA; Furutani KM; Camp JJ; Robb RA
    Brachytherapy; 2014; 13(5):465-70. PubMed ID: 24962657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of intraoperative dosimetric implant representation with postimplant dosimetry in patients receiving prostate brachytherapy.
    Stone NN; Hong S; Lo YC; Howard V; Stock RG
    Brachytherapy; 2003; 2(1):17-25. PubMed ID: 15062159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of dose length, area, and volume histograms as quantifiers of urethral dose in prostate brachytherapy.
    Butler WM; Merrick GS; Dorsey AT; Hagedorn BM
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1575-82. PubMed ID: 11121664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.